-

MERGER ALERT: Kaskela Law LLC Announces Stockholder Investigation of MoneyLion Inc. (ML) and Encourages Investors to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating MoneyLion Inc. (NYSE: ML) on behalf of the company’s shareholders.

MoneyLion shareholders are encouraged to contact Kaskela Law LLC at (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or online at https://kaskelalaw.com/case/moneylion/, to receive additional information about this investigation and their legal rights and options.

On December 10, 2024, MoneyLion announced that it had agreed to be acquired by Gen Digital Inc. at a price of $82.00 per share in cash. Following the closing of the transaction, MoneyLion’s stockholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.

Kaskela Law LLC’s investigation seeks to determine whether $82.00 per share represents adequate consideration for MoneyLion’s shares, and if the proposed transaction as currently structured is fair to MoneyLion’s stockholders. Notably, at the time the buyout was announced, several stock analysts were maintaining price targets for ML shares of over $100.00 per share.

MoneyLion shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 to receive additional information about this investigation and their legal rights and options. Alternatively, investors may contact the firm by clicking on the following link (or if necessary, by copying and pasting the link into your browser):

https://kaskelalaw.com/case/moneylion/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

This notice may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

Kaskela Law LLC

NYSE:ML

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

Kaskela Law LLC Announces Investigation into Fairness of $9.50 Per Share Global Business Travel Group (GBTG) Stockholder Buyout; Affected Investors are Encouraged to Contact the Firm to Protect Their Investment and Legal Rights

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Kaskela Law is investigating the fairness of the recently announced buyout of Global Business Travel Group, Inc. (NYSE: GBTG) (“GBTG”) shareholders to determine whether the transaction as structured provides investors with a sufficient price for their GBTG shares. Click here to register for additional information about this investigation: https://kaskelalaw.com/case/global-business-travel-group/ On May 4, 2026, GBTG announced that it had agreed to go privat...

Kaskela Law LLC Announces Shareholder Investigation of Playtika Holding Corp. and Encourages Investors with Losses to Contact the Firm – PLTK

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Shareholder litigation law firm Kaskela Law is investigating Playtika Holding Corp. (NASDAQ: PLTK) (“Playtika”) on behalf of the company’s investors. Click here to register for additional information about this investigation: https://kaskelalaw.com/case/playtika-holding/ Since July 2025, shares of Playtika’s common stock have declined in value from a trading price of over $4.50 per share to a current price of less than $3.50 per share, a decline of over 22%...

Kaskela Law LLC Announces Investigation into Fairness of $16.50 Per Share Select Medical Holdings (SEM) Stockholder Buyout; Affected Investors are Encouraged to Contact the Firm to Protect Their Investment and Legal Rights

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Shareholder litigation law firm Kaskela Law is investigating the fairness of the recently announced buyout of Select Medical Holdings Corp. (NYSE: SEM) (“Select Medical”) shareholders to determine whether the transaction as structured provides investors with a sufficient price for their shares. Click here to register for additional information about this investigation: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced th...
Back to Newsroom